Gainesville, FL, United States of America

Hendrik Luesch

USPTO Granted Patents = 15 (Patent Applications = 17)

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

15 out of 2,925

University of Florida Research Foundation, Incorporated

patents

5 out of 18

Smithsonian Institution

Smithsonian Institute

patent

5. 1 out of 1

Smithsonian Institutution

patent

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11718645 - Macrocyclic therapeutic agents, methods of manufacture, and methods of treatment (2023-08-08),

2. 11358989 - Apratyramide therapeutic agents and methods of treatment (2022-06-14),

3. 11242331 - Analogs of yohimbine and uses thereof (2022-02-08),

4. 11130764 - Analogs of vincamine and uses thereof (2021-09-28),

5. 10010569 - Seaweed extracts, unsaturated fatty acids, and methods of treatment (2018-07-03),

6. 9815852 - Macrocyclic compounds and methods of treatment (2017-11-14),

7. 9730970 - Seaweed extracts, unsaturated aldehydes, and methods of treatment (2017-08-15),

8. 9492434 - Combination compositions and methods of treatment (2016-11-15),

9. 9181304 - Macrocyclic therapeutic agents and methods of treatment (2015-11-10),

10. 9051350 - Macrocyclic antiproliferation agents and methods of treatment (2015-06-09),

11. 9023875 - Macrocyclic compounds and methods of treatment (2015-05-05),

12. 8759512 - Methods of preparation of macrocyclic compounds (2014-06-24),

13. 8569245 - Protease inhibitors, compositions and methods of use (2013-10-29),

14. 8357708 - Macrocyclic compounds and methods of treatment (2013-01-22),

15. 8129418 - Macrocyclic compounds and methods of treatment (2012-03-06),

Title: The Innovations of Hendrik Luesch

Introduction

Hendrik Luesch, an esteemed inventor based in Gainesville, FL, has made significant contributions to the field of therapeutic agents through his innovative spirit. With a portfolio of 15 patents, Luesch has dedicated his career to developing solutions for complex health issues.

Latest Patents

Among his latest patents are groundbreaking innovations in macrocyclic therapeutic agents. This invention encompasses macrocyclic compounds that exhibit therapeutic activity, specifically targeting disorders such as autoimmune diseases, inflammation, and cancers related to tumors and cell proliferation. Another notable patent by Luesch focuses on Apratyramide therapeutic agents, which includes linear depsipeptide compounds aimed at enhancing wound healing processes. His work offers methods that address inflammation, cell proliferation, and the remodeling of scar tissue.

Career Highlights

Hendrik Luesch has had an impressive career, contributing his expertise to renowned institutions like the University of Florida Research Foundation and the Smithsonian Institution. His research has paved the way for advancements in therapeutic applications, showcasing his commitment to improving health through innovation.

Collaborations

Throughout his career, Luesch has collaborated with esteemed professionals including Valerie J Paul and Taori Kanchan. These partnerships have enriched his research and have amplified the impact of his inventions in the scientific community.

Conclusion

Hendrik Luesch exemplifies the spirit of innovation in the medical field, with a focus on creating therapeutic agents that address critical health challenges. His contributions underscore the importance of research and collaboration in the journey toward meaningful discoveries that benefit society.

This text is generated by artificial intelligence and may not be accurate.